The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Open accessAbstract
The cardiovascular toxicity of older generation of tricyclic antidepressants (e.g. imipramine, desipramine, amitriptyline, clomipramine) and neuroleptics (e.g. haloperidol, droperidol, thioridazine, pimozide) is well established. These drugs inhibit cardiovascular Na(+), Ca(2+) and K(+) channels often leading to life-threatening arrhythmia. To overcome the toxicity of old generation of antidepressants and antipsychotics, selective serotonin reuptake inhibitor antidepressants (SSRIs: fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram, venlafaxin) and several new antipsychotics (e.g. clozapine, olanzapine, risperidone, sertindole, aripiprazole, ziprasidone, quetiapine) were introduced during the past decade. Although these new compounds are not more effective in treating psychiatric disorders than older medications, they gained incredible popularity since they have been reported to have fewer and more benign side effect profile (including cardiovascular) than predecessors. Surprisingly, an increasing number of case reports have demonstrated that the use of SSRIs and new antipsychotics (e.g. clozapine, olanzapine, risperidone, sertindole, aripiprazole, ziprasidone, quetiapine) is associated with cases of arrhythmias, prolonged QTc interval on electrocardiogram (ECG) and orthostatic hypotension in patients lacking cardiovascular disorders, raising new concerns about the putative cardiovascular safety of these compounds. In agreement with these clinical reports these new compounds indeed show marked cardiovascular depressant effects in different mammalian and human cardiovascular preparations by inhibiting cardiac and vascular Na(+), Ca(2+) and K(+) channels. Taken together, these results suggest that the new generation of antidepressants and antipsychotics also have clinically important cardiac as well as vascular effects. Clinicians should be more vigilant about these potential adverse reactions and ECG control may be suggested during therapy, especially in patients with cardiovascular disorders. The primary goal of this review is to shed light on the recently observed clinically important cardiovascular effects of new antidepressants and antipsychotics and discuss the mechanism beyond this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,354
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Burris, K. D., Molski, T. F., Xu, C., Ryan, E., Tottori, K., Kikuchi, T., Yocca, F. D., & Molinoff, P. B. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033175 · Cited by 922
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 822
Wong, D. T., Bymaster, F. P., & Engleman, E. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00209-o · Cited by 647
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
Reilly, J., Ayis, S., Ferrier, I., Jones, S., & Thomas, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02035-3 · Cited by 602
Myocarditis and cardiomyopathy associated with clozapine
Kilian, J. G., Kerr, K., Lawrence, C., & Celermajer, D. S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10385-4 · Cited by 544
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
Jordan, S., Koprivica, V., Chen, R., Tottori, K., Kikuchi, T., & Altar, C. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01532-7 · Cited by 512
The impact of drug-induced QT interval prolongation on drug discovery and development
Fermini, B., & Fossa, A. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1108 · Cited by 492
Haverkamp*, W. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00119-x · Cited by 486
Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death
Haddad, P. M., & Anderson, I. M. (2002) · Drugs · doi:10.2165/00003495-200262110-00006 · Cited by 435
Antipsychotics and the Risk of Sudden Cardiac Death
Ray, W. A., Meredith, S., Thapa, P. B., Meador, K. G., Hall, K., & Murray, K. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1161 · Cited by 429
Comparison of potassium currents in rabbit atrial and ventricular cells.
Giles, W. R., & Imaizumi, Y. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017325 · Cited by 381
Inhibition of Neuronal Na+ Channels by Antidepressant Drugs
Pancrazio, J. J., Kamatchi, G. L., Roscoe, A. K., & Lynch, C. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37206-4 · Cited by 311
Ponti, F. D., Poluzzi, E., Cavalli, A., Recanatini, M., & Montanaro, N. (2002) · Drug Safety · doi:10.2165/00002018-200225040-00004 · Cited by 309
Cardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants: A Review
Glassman, A. H. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780320095011 · Cited by 269
The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered
Glassman, A. H. (1993) · JAMA · doi:10.1001/jama.269.20.2673 · Cited by 245
A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs
Kongsamut, S., Kang, J., Chen, X.-L., Roehr, J., & Rampe, D. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02074-5 · Cited by 242
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
De Ponti, F., Poluzzi, E., & Montanaro, N. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050714 · Cited by 240
Suessbrich, H., Schönherr, R., Heinemann, S. H., Attali, B., Lang, F. J. W., & Busch, A. E. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700989 · Cited by 229
Psychotropic Drugs, Cardiac Arrhythmia, and Sudden Death
Witchel, H. J., Hancox, J. C., & Nutt, D. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00010 · Cited by 221
Sudden death in psychiatric patients
Ruschena, D., Mullen, P. E., Burgess, P., Cordner, S., Barry-Walsh, J., Drummer, O., Palmer, S., Browne, C., & Wallace, C. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.4.331 · Cited by 217
Cardiovascular Effects of Fluoxetine in Depressed Patients With Heart Disease
Roose, S. P., Glassman, A. H., Attia, E., Woodring, S., Giardina, E.-G. V., & Bigger, J. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.660 · Cited by 212
In Vitro Approaches to Predicting Drug Interactions In Vivo
von Moltke, L. L., Greenblatt, D. J., Schmider, J., Wright, C. E., Harmatz, J. S., & Shader, R. I. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00239-6 · Cited by 197
Cardiac Antiarrhythmic Effect of Imipramine Hydrochloride
Bigger, J. T., Giardina, E. G. V., Perel, J. M., Kantor, S. J., & Glassman, A. H. (1977) · New England Journal of Medicine · doi:10.1056/nejm197701272960407 · Cited by 196
Mehtonen, O. ‐., Aranko, K., Mälkonen, L., & Vapaatalo, H. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb01421.x · Cited by 187
Rampe, D., Murawsky, M. K., Grau, J., & Lewis, E. W. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37654-2 · Cited by 172
Familial And Acquired Long QT Syndrome And The Cardiac Rapid Delayed Rectifier Potassium Current
Witchel, H. J., & Hancox, J. C. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03337.x · Cited by 170
Giardina, E. G., Bigger, J. T., Glassman, A. H., Perel, J. M., & Kantor, S. J. (1979) · Circulation · doi:10.1161/01.cir.60.5.1045 · Cited by 167
Agelink, M. W., Majewski, T., Wurthmann, C., Lukas, K., Ullrich, H., Linka, T., & Klieser, E. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00003 · Cited by 166
Cardiotoxicity More Common in Thioridazine Overdose than with Other Neuroleptics
Buckley, N. A., Whyte, I. M., & Dawson, A. H. (1995) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659509017984 · Cited by 159
Tricyclic Antidepressants in Depressed Patients With Cardiac Conduction Disease
Roose, S. P. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150093011 · Cited by 157
CLINICAL CHARACTERISTICS OF IMIPRAMINE-INDUCED ORTHOSTATIC HYPOTENSION
Glassman, A. H., Bigger, J. T., GGiardina, E., Kantor, S. J., Perel, J., & Davies, M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90824-9 · Cited by 156
Cardiovascular Effects of Tricyclic and Tetracyclic Antidepressants
BURCKHARDT, D., Raeder, E., Müller, V., Imhof, P., & Neubauer, H. (1978) · JAMA · doi:10.1001/jama.1978.03280300045019 · Cited by 154
Contributions of a transient outward current to repolarization in human atrium
Shibata, E. F., Drury, T., Refsum, H., Aldrete, V., & Giles, W. R. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.6.h1773 · Cited by 152
Sudden Death in Children Treated with a Tricyclic Antidepressant
Biederman, J. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199105000-00023 · Cited by 148
Myocarditis Related to Clozapine Treatment
Hägg, S., Spigset, O., BAHons, A. B., & Söderström, T. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00005 · Cited by 140
Teschemacher, A. G., Seward, E. P., Hancox, J. C., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702800 · Cited by 135
Electrocardiographic changes in patients receiving neuroleptic medication
Warner, J. P., Barnes, T. R. E., & Henry, J. A. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10653.x · Cited by 133
Prolongation of QT Interval in Isolated Feline Hearts by Antipsychotic Drugs
Drici, M., Wang, W. X., Liu, X., Woosley, R. L., & Flockhart, D. A. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00011 · Cited by 132
Vohra, J., Burrows, G. D., Hunt, D. U., & Sloman, G. (1975) · PubMed · Cited by 126
Witchel, H. J., Pabbathi, V. K., Hofmann, G., Paul, A. A., & Hancox, J. C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03320-8 · Cited by 126
Metzger, E., & Friedman, R. A. (1993) · PubMed · Cited by 126
Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells
Deák, F., Lasztóczi, B., Pacher, P., Petheö, G. L., Kecskeméti, V., & Spät, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00206-3 · Cited by 124
Self-citationPacher, P., Ungvari, Z. I., Nánási, P. P., Fürst, S., & Kecskeméti, V. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220330184544 · Cited by 121
Self-citationCzekalla, J., Beasley, C. M., Dellva, M. A., Berg, P. H., & Grundy, S. L. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0310 · Cited by 121
The Association Between Intravenous Haloperidol and Torsades de Pointes
Hunt, N., & Stern, T. A. (1995) · Psychosomatics · doi:10.1016/s0033-3182(95)71609-7 · Cited by 120
Thomas, D., Gut, B., Wendt‐Nordahl, G., & Kiehn, J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.543 · Cited by 117
Drolet, B., Zhang, S., Deschênes, D., Rail, J., NADEAU, S., Zhou, Z., January, C. T., & Turgeon, J. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00224.x · Cited by 116
de la Torre, B. R., Dreher, J., Malevany, I., Bagli, M., Kolbinger, M., Omran, H., Lüderitz, B., & Rao, M. L. (2001) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200108000-00019 · Cited by 113
Drolet, B., Vincent, F., Rail, J., Chahine, M., Deschênes, D., Nadeau, S., Khalifa, M., Hamelin, B. A., & Turgeon, J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38082-6 · Cited by 113
Mj, B., Starmer, C. F., & Grant, A. O. (1991) · Circulation Research · doi:10.1161/01.res.69.3.677 · Cited by 97
Acquired Long QT Syndromes and the Risk of Proarrhythmia
Roden, D. M. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb00077.x · Cited by 95
Inhibition of G protein‐activated inwardly rectifying K+ channels by fluoxetine (Prozac)
Kobayashi, T., Washiyama, K., & Ikeda, K. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705172 · Cited by 89
ARIPIPRAZOLE: A REVIEW OF ITS PHARMACOLOGY AND CLINICAL USE
Taylor, D. M. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb11397.x · Cited by 88
Pato, M. T., Murphy, D. L., & DeVane, L. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199106000-00024 · Cited by 87
Mechanism of Fluoxetine Block of Cloned Voltage-Activated Potassium Channel Kv1.3
Choi, J., Hahn, S. J., Rhie, D., Yoon, S. H., Jo, Y., & Kim, M.-S. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35063-3 · Cited by 85
Zarate, A., Baldessarini, R. J., Siegel, A. J., et al. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0705 · Cited by 82
Treatment of depression in patients with heart disease
Roose, S. P. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00320-2 · Cited by 81
Pacher, P., & Ungvari, Z. I. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1366 · Cited by 80
Self-citationFluoxetine-induced bradycardia and syncope in two patients.
Ellison, J. M., Milofsky, J. E., & Ely, E. (1990) · PubMed · Cited by 80
Effect of fluoxetine on a neuronal, voltage‐dependent potassium channel (Kv1.1)
Tytgat, J., Maertens, C., & Daenens, P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701545 · Cited by 79
Blockade of the HERG human cardiac K+ channel by the antidepressant drug amitriptyline
Jo, S., Youm, J. B., Lee, C. O., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703222 · Cited by 78
Flockhart, D. A., Drici, M., Kerbusch, T., Soukhova, N. V., Richard, E., Pearle, P. L., Mahal, S. K., & Babb, V. J. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00005 · Cited by 73
Life-Threatening Ventricular Arrhythmia (Torsades de Pointes) after Haloperidol Overdose
Henderson, R. A., Lane, S. M., & Henry, J. A. (1991) · Human & Experimental Toxicology · doi:10.1177/096032719101000110 · Cited by 72
Risk of syncope in the elderly and consumption of drugs: A case-control study
Cherin, P., Colvez, A., de Périère, D. D., & Séréni, D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00385-x · Cited by 67
Beelen, A. P., Yeo, K. L. B., & Lewis, L. D. (2001) · Human & Experimental Toxicology · doi:10.1191/096032701678766778 · Cited by 64
Wang, S., Su, C., & Kuo, Y. (2003) · Synapse · doi:10.1002/syn.10200 · Cited by 63
Шуба, Я. М., Degtiar, V. E., Osipenko, V. N., Naidenov, V. G., & Woosley, R. L. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00611-6 · Cited by 62
Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease.
Buff, D. D., Brenner, R., Kirtane, S. S., & Gilboa, R. (1991) · PubMed · Cited by 59
Drolet, B., Yang, T., Daleau, P., Roden, D. M., & Turgeon, J. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200306000-00016 · Cited by 59
Ungvari, Z. I., Pacher, P., Kecskeméti, V., & Koller, Á. (1999) · Stroke · doi:10.1161/01.str.30.9.1949 · Cited by 58
Self-citationElectrophysiological effects of fluoxetine in mammalian cardiac tissues
Pacher, P., Magyar, J., Szigligeti, P., Bányász, T., Pankucsi, C., Korom, Z., Ungvari, Z. I., Kecskeméti, V., & Nánási, P. P. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900154 · Cited by 58
Self-citationPacher, P., Ungvari, Z. I., Kecskeméti, V., et al. (1998) · PubMed · Cited by 52
Self-citationFluoxetine inhibits L-type Ca2+and transient outward K+currents in rat ventricular myocytes
Park, K., Kong, I. D., Park, K. C., & Lee, J. W. (1999) · Yonsei Medical Journal · doi:10.3349/ymj.1999.40.2.144 · Cited by 51
The heart of psychotropic drug therapy
Tie, H., Walker, B., Valenzuela, S. M., Breit, S., & Campbell, T. (2000) · The Lancet · doi:10.1016/s0140-6736(05)73083-x · Cited by 50
Fluoxetine-induced cardiotoxicity with response to bicarbonate therapy
Graudins, A., Vossler, C., & Wang, R. T. (1997) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(97)90194-7 · Cited by 42
Fluoxetine-induced inhibition of synaptosomal [3H] 5-HT release: Possible CA2+-channel inhibition
Stauderman, K. A., Gandhi, V. C., & Jones, D. J. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90579-e · Cited by 39
Terstappen, G. C., Pellacani, A., Aldegheri, L., et al. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00574-3 · Cited by 39
Heart block in a patient on propranolol and fluoxetine
Drake, W. M., & Gordon, G. D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91265-3 · Cited by 38
Bou‐Abboud, E., & Nattel, S. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00011-x · Cited by 35
Reeve, H. L., Nelson, D. P., Archer, S. L., & Weir, Ε. K. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.2.l213 · Cited by 30
Unexpected deaths in depressed medical inpatients treated with fluoxetine.
Spier, S. A., & Frontera, M. A. (1991) · PubMed · Cited by 30
Fluoxetine-Associated Potentiation of Calcium-Channel Blockers
Sternbach, H. A. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199112000-00019 · Cited by 29
Block of volume-regulated anion channels by selective serotonin reuptake inhibitors
Maertens, C., DROOGMANS, G., Verbesselt, R., & Nilius, B. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0567-5 · Cited by 28
Boeck, V., J�rgensen, A., & Over�, K. F. (1984) · Psychopharmacology · doi:10.1007/bf00427669 · Cited by 28
Probable Terfenadine-Fluoxetine-Associated Cardiac Toxicity
Marchiando, R. J., Cook, M. D., & Jue, S. G. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900922 · Cited by 27
Block of Na+ channels by imipramine in guinea-pig cardiac ventricular cells.
Habuchi, Y., Furukawa, T., Tanaka, H., Tsujimura, Y., & Yoshimura, M. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23044-0 · Cited by 24
Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance
Pezawas, L., Quiner, S., Moertl, D., Tauscher, J. T., Barnas, C., Kufferle, B., Wolf, R. C., & Kasper, S. F. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015040-00003 · Cited by 23
Fluoxetine blocks cloned neuronal A-type K+ channels Kv1.4
Choi, B. H., Choi, J., Ahn, H. S., Kim, M.-J., Rhie, D., Yoon, S.-H., Min, D., Jo, Y., Kim, M., & Hahn, S. J. (2003) · Neuroreport · doi:10.1097/00001756-200312190-00032 · Cited by 23
Drug-induced supraventricular tachycardia: A case report of fluoxetine
Gardner, S. F., Rutherford, W. F., Munger, M. A., et al. (1991) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)81222-3 · Cited by 19
Bradycardia associated with fluoxetine in an elderly patient with sick sinus syndrome
Hussein, S., & Kaufman, B. (1994) · Postgraduate Medical Journal · doi:10.1136/pgmj.70.819.56 · Cited by 14
Cited by
Marroquin, L. D., Hynes, J., Dykens, J. A., Jamieson, J. D., & Will, Y. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm052 · Cited by 628
Pathophysiology of Heart Failure
Tanai, E., & Frantz, S. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140055 · Cited by 552
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Howes, O. D., Rogdaki, M., Findon, J. L., Wichers, R. H., Charman, T., King, B. H., Loth, E., McAlonan, G. M., McCracken, J. T., Parr, J. R., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117741766 · Cited by 342
Evolution of Biochip Technology: A Review from Lab-on-a-Chip to Organ-on-a-Chip
Azizipour, N., Avazpour, R., Rosenzweig, D. H., Sawan, M., & Ajji, A. (2020) · Micromachines · doi:10.3390/mi11060599 · Cited by 277
Metadata
- Authors
- Pacher, P., & Kecskemeti, V.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2004-08-01
- Volume
- 10
- Issue
- 20
- Pages
- 2463-2475
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2053048310
- Cited by
- 390
- References
- 92
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.